Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Sara J. McKee"'
Autor:
Sara J. McKee, Zewen K. Tuong, Takumi Kobayashi, Brianna L. Doff, Megan SF Soon, Michael Nissen, Pui Yeng Lam, Colm Keane, Frank Vari, Davide Moi, Roberta Mazzieri, Graham Leggatt, Maher K. Gandhi, Stephen R. Mattarollo
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Monocytosis is considered a poor prognostic factor for many cancers, including B cell lymphomas. The mechanisms by which different monocyte subsets support the growth of lymphoma is poorly understood. Using a pre-clinical mouse model of B cell non-Ho
Externí odkaz:
https://doaj.org/article/5598b069cc7b452b8f1ee3c736e64cbf
Autor:
Richard Linedale, Graham R. Leggatt, Arthur Wong, Trevor Long, Sara J. McKee, Lucy Woolford, Janet M. Lanyon
Publikováno v:
Veterinary Immunology and Immunopathology. 200:16-25
Species-specific antibodies (Ab) for the measurement of immunoglobulins (Ig) are valuable tools for determining the humoral immune status of threatened and endangered wildlife species such as dugongs. However, no studies have reported antibody reagen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3787cc9f1499bf88c6151b675a12ef51
https://doi.org/10.1016/j.vetimm.2018.04.003
https://doi.org/10.1016/j.vetimm.2018.04.003
Autor:
Takumi Kobayashi, Graham R. Leggatt, Sara J. McKee, Rory C Rearden, Stephen R. Mattarollo, Brianna L. Doff, Amelia Sah
Publikováno v:
Immunology & Cell Biology. 94:554-562
Immunomodulatory therapies can effectively control haematological malignancies by promoting antitumour immunity. Previously, we reported transient growth of poorly immunogenic murine non-Hodgkin B-cell lymphomas (B-NHL) by targeting natural killer T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ace41b785dbc087bffc6d3c56c88aec9
https://doi.org/10.1038/icb.2016.9
https://doi.org/10.1038/icb.2016.9
Publikováno v:
Reviews in Medical Virology. 25:54-71
It has been more than 7 years since the commercial introduction of highly successful vaccines protecting against high-risk human papillomavirus (HPV) subtypes and the development of cervical cancer. From an immune standpoint, the dependence of cervic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::83c6f04b1de1363a02dcb56bd59daa47
https://doi.org/10.1002/rmv.1824
https://doi.org/10.1002/rmv.1824
Publikováno v:
Cancer immunology research. 5(3)
Combinations of mAbs that target various components of T-cell activation/inhibition may work synergistically to improve antitumor immunity against cancer. In this study, we investigated the therapeutic potential of combining an anticancer vaccination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30e70d40748cf428b3776bfe6472f196
https://pubmed.ncbi.nlm.nih.gov/28115358
https://pubmed.ncbi.nlm.nih.gov/28115358
Autor:
Pui Yeng Lam, Sara J. McKee, Michael D. Nissen, Takumi Kobayashi, Roberta Mazzieri, Colm Keane, Brianna L. Doff, Zewen K. Tuong, Graham R. Leggatt, Megan S. F. Soon, Maher K. Gandhi, Stephen R. Mattarollo, Frank Vari, Davide Moi
Publikováno v:
OncoImmunology, Vol 7, Iss 2 (2018)
Monocytosis is considered a poor prognostic factor for many cancers, including B cell lymphomas. The mechanisms by which different monocyte subsets support the growth of lymphoma is poorly understood. Using a pre-clinical mouse model of B cell non-Ho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb7ef12eb15cfe9877ee0d5522e01f0
https://doi.org/10.1080/2162402x.2017.1393599
https://doi.org/10.1080/2162402x.2017.1393599
Autor:
Fawzi Bokhari, Nigel A.J. McMillan, Melanie Murrell, H. Peter Soyer, Graham R. Leggatt, Karin Sedelies, Brian Gabrielli, Zay Yar Oo, Weili Wang, Mushfiq Hassan Shaikh, Melinda E. Christensen, Sora Fallaha, Dubravka Skalamera, Max V. Ranall, Alexander J. Stevenson, Thomas J. Gonda, Madison Kelly, Daniel Clarke, Sara J. McKee, Paul Leo
Publikováno v:
Molecular cancer therapeutics. 14(12)
Human papillomavirus (HPV) is the causative agent in cervical cancer. HPV oncogenes are major drivers of the transformed phenotype, and the cancers remain addicted to these oncogenes. A screen of the human kinome has identified inhibition of Aurora k
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6f9123a6b8d8318255b2cc071ad647b
https://pubmed.ncbi.nlm.nih.gov/26516156
https://pubmed.ncbi.nlm.nih.gov/26516156
Publikováno v:
Reviews in medical virology. 25
It has been more than 7 years since the commercial introduction of highly successful vaccines protecting against high-risk human papillomavirus (HPV) subtypes and the development of cervical cancer. From an immune standpoint, the dependence of cervic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::181b6dfa0fb5183aaf6a94fc61da06c7
https://pubmed.ncbi.nlm.nih.gov/25752816
https://pubmed.ncbi.nlm.nih.gov/25752816
Publikováno v:
Journal of leukocyte biology. 96(1)
The skin is a complex immunological niche providing immunity to invading pathogens while simultaneously maintaining tolerance to innocuous environmental antigens. Consistent with this complex response, the skin is resident to both immunosuppressive a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bc9597e4dae97937ab2d3f4dc4630bd4
https://pubmed.ncbi.nlm.nih.gov/24799605
https://pubmed.ncbi.nlm.nih.gov/24799605
Autor:
Sara J. McKee, Vernon K. Ward, Margaret A. Baird, Khairunadwa Jemon, Sarah L. Young, Michelle Wilson, Vivienne L. Young, Merilyn Hibma
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 6, p e66866 (2013)
PLoS ONE, Vol 8, Iss 6, p e66866 (2013)
Cervical cancer is caused by high-risk, cancer-causing human papillomaviruses (HPV) and is the second highest cause of cancer deaths in women globally. The majority of cervical cancers express well-characterized HPV oncogenes, which are potential tar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa5e4b78de2b341953be62362d15de51
https://pubmed.ncbi.nlm.nih.gov/23799135
https://pubmed.ncbi.nlm.nih.gov/23799135